MedPath

Study about the high flow and conventional oxigen therapy in patients with severe acute respiratory failure.

Conditions
Severe acute respiratory failure
Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Registration Number
EUCTR2012-001671-36-ES
Lead Sponsor
Fundación para la Investigación Biomédica
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

?Patients of both major sexes of 18 years joined UCI. ?severe acute respiratory failure defined clinical for: peripheral Saturation of oxygen (SatO2p by means of pulsioximetria) <94 % respiratory superior Frequency to 30 r/min during 30 minutes with mask of venturi to 60 %, with or without pulmonary infiltrators in X-ray photography of thorax.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 95
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 95

Exclusion Criteria

?Glasgow <11 ? Need of urgent intubation ?sharp Agitation without collaboration of the patient ? Shock with instability hemodinámica that does not answer to volume and aminas vasoactivas. ? Any patient who to criterion of the investigator could not expire with the specifications of the protocol

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath